Literature DB >> 1959879

Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease.

D J Morgan1, A J McLean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1959879

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

Review 1.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study).

Authors:  Saad Zaky; Ehab Ahmad Fouad; Hassan Ibrahim Mohamad Kotb
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.

Authors:  O Rosmorduc; D Wendum; C Corpechot; B Galy; N Sebbagh; J Raleigh; C Housset; R Poupon
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 4.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

Review 5.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

Review 6.  Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.

Authors:  D J Morgan; A J McLean
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

7.  Steady-state pharmacokinetics of roflumilast and roflumilast N-oxide in patients with mild and moderate liver cirrhosis.

Authors:  Robert Hermann; Nassr Nassr; Gezim Lahu; Eva Péterfai; Dietrich Knoerzer; Rolf Herzog; Karl Zech; Christian de Mey
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Analgesics in patients with hepatic impairment: pharmacology and clinical implications.

Authors:  Marija Bosilkovska; Bernhard Walder; Marie Besson; Youssef Daali; Jules Desmeules
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

9.  Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.

Authors:  Toshishige Shibamoto; Chiaki Kamikado; Shozo Koyama
Journal:  Pflugers Arch       Date:  2008-01-05       Impact factor: 3.657

10.  The assessment and management of pain in cirrhosis.

Authors:  Matthew Klinge; Tami Coppler; Jane M Liebschutz; Mohannad Dugum; Ajay Wassan; Andrea DiMartini; Shari Rogal
Journal:  Curr Hepatol Rep       Date:  2018-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.